Status:
COMPLETED
Five-year Migration Pattern and Bone Mineral Density for the Tri-Lock and Summit Femoral Stems.
Lead Sponsor:
Regional Hospital Holstebro
Conditions:
THA
Eligibility:
All Genders
40-70 years
Phase:
NA
Brief Summary
The incidence of primary hip joint prosthesis is 180 per. 100,000 inhabitants. In male patients younger than 50 years the 10-years survival of the prosthesis is 89 % and 82 % over 15 years. In women y...
Detailed Description
BACKGROUND According to the Danish Hip Arthroplasty Registry 201 approximately 10.400 primary hip joint prostheses in Denmark are implanted annually, and the incidence is relatively stable. The incid...
Eligibility Criteria
Inclusion
- Patients with primary hip osteoarthritis
- Patients with adequate bone stock for insertion of uncemented components(no osteoporosis as assessed by pre-operative dual-energy x-ray absorptiometry (DXA) scans)
- Informed, written consent
Exclusion
- Patients with neuromuscular or vascular diseases in the affected leg
- Patients intraoperatively found unfit to uncemented components
- Patients who can not refrain from the use of non-steroidal anti-inflammatory drugs (NSAIDs) in post-operative recovery
- Patients with pre-operative fracture sequelae
- Women who are, or have a wish for pregnancy during the study period.
- Hip dysplasia or sequelae to Calves Perthes.
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 10 2023
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06019026
Start Date
January 1 2015
End Date
June 10 2023
Last Update
September 28 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.